Jenelle Krishnamoorthy, Vice President and Head of Global Public Policy, Corporate Affairs, Merck & Co.: “Driving Meaningful and Sustained Progress on AMR”

Subscribe and Listen

In this episode Merck’s Jenelle Krishnamoorthy, a member of the CSIS Bipartisan Alliance for Global Health Security, joins Katherine to discuss the growing challenge of antimicrobial resistance (AMR); the importance of incentivizing research and development of new amicrobials, even as there is pressure to use them in a limited way; plans for a United Nations High-Level Meeting on AMR in 2024; and opportunities to improve funding, governance and international collaboration to meet the global threat of AMR in the years to come.

Katherine E. Bliss
Senior Fellow and Director, Immunizations and Health Systems Resilience, Global Health Policy Center